JPS6497A - 16-membered ring macrolide compound - Google Patents

16-membered ring macrolide compound

Info

Publication number
JPS6497A
JPS6497A JP15482687A JP15482687A JPS6497A JP S6497 A JPS6497 A JP S6497A JP 15482687 A JP15482687 A JP 15482687A JP 15482687 A JP15482687 A JP 15482687A JP S6497 A JPS6497 A JP S6497A
Authority
JP
Japan
Prior art keywords
formula
coc
membered ring
compound shown
macrolide compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15482687A
Other languages
Japanese (ja)
Other versions
JPH0197A (en
Inventor
Youji Mitadera
Hiroshi Shinkai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Priority to JP15482687A priority Critical patent/JPS6497A/en
Publication of JPH0197A publication Critical patent/JPH0197A/en
Publication of JPS6497A publication Critical patent/JPS6497A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A compound shown by formula I [n is 0 or 1; R0 is H or alkyl; A is OH, =0 or group shown by formula II; R1 is OCH3 or CH3; R2 is H or CH3; R3 is H, CH3, CH2OH or group shown by formula III; R4 is CH3 of C2H5; R5 is H, COCH3 or COC2H5; R6 is H or COC2H5, COC3H7 or COCH2 CH(CH3)2] and an acid addition salt thereof.
EXAMPLE: A compound shown by formula IV.
USE: An antimicrobial agent for oral administration.
PREPARATION: A compound shown by formula V is reacted with a mercaptocarboxylic acid in an organic solvent containing no active hydrogen in the presence of 1,3-dicyclohexylcarbodiimide and optionally a base at -25W60°C for 1W6 days.
COPYRIGHT: (C)1989,JPO&Japio
JP15482687A 1987-06-22 1987-06-22 16-membered ring macrolide compound Pending JPS6497A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15482687A JPS6497A (en) 1987-06-22 1987-06-22 16-membered ring macrolide compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15482687A JPS6497A (en) 1987-06-22 1987-06-22 16-membered ring macrolide compound

Publications (2)

Publication Number Publication Date
JPH0197A JPH0197A (en) 1989-01-05
JPS6497A true JPS6497A (en) 1989-01-05

Family

ID=15592725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15482687A Pending JPS6497A (en) 1987-06-22 1987-06-22 16-membered ring macrolide compound

Country Status (1)

Country Link
JP (1) JPS6497A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2012000933A1 (en) 2011-04-14 2014-07-25 Harnischfeger Tech Inc A method and a cable shovel for the generation of an ideal path, comprises: an oscillation engine, a hoisting engine, a feed motor, a bucket for digging and emptying materials and, positioning the shovel by means of the operation of the lifting motor, feed motor and oscillation engine and; a controller that includes an ideal path generator module.

Similar Documents

Publication Publication Date Title
HU908443D0 (en) Process for the production of peptides
GR3023219T3 (en) Pyrazolopyridine compounds and processes for preparation thereof
ATE146473T1 (en) PYRAZOLOPYRIDINE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
GB8826595D0 (en) Active compounds
DE3850603D1 (en) Arylaralkyl ethers, process for their preparation and pharmaceutical composition containing them.
EP0281412A3 (en) Novel organic platinum complex pharmaceutical compositions containing same and a process for the preparation thereof
SE9703056L (en) Clavulanic acid salts, process for their preparation and pharmaceutical compositions containing them
HUT49887A (en) Process for producing new cefem compounds
JPS56118015A (en) Immunological activator containing organic germanium compound
JPS572298A (en) Erythromycin derivative
JPS55164672A (en) Azetidine derivative and its preparation
JPS55111470A (en) Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
GB8608893D0 (en) D-nor-7-ergoline derivatives
JPS57139015A (en) Remedy for infectious disease for oral administration
JPS5569569A (en) Carcinostatic
ATE97902T1 (en) CEPHEM COMPOUNDS AND PROCESSES FOR THEIR PRODUCTION.
JPS643144A (en) Novel cyclic compound and antilipemic agent containing said compound as active component
BG95629A (en) Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations
JPS54135771A (en) Novel antibiotic substance 4a-epinanaomycin b and its preparation
JPS5387358A (en) Gamma-pyrone compound, its preparation and agricultural medicine therefrom
JPS5444696A (en) Condensed isoxazole compound and its preparation
JPS5645473A (en) Preparation of 6-fluoro-1,8-naphthyridine derivative
JPS5782376A (en) Novel antibiotic substance saphenamycin and its preparation
JPS5675431A (en) Hypoglycemic agent containing ethyl piperidylacetylaminobenzoate